ID   CHLA-8
AC   CVCL_6609
DR   Wikidata; Q54812508
RX   PubMed=9850071;
RX   PubMed=11507071;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 30,30.2
ST   D2S1338: 18,19
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
RX   PubMed=9850071;
RA   Keshelava, Nino
RA   Seeger, Robert C.
RA   Groshen, Susan
RA   Reynolds, Charles Patrick
RT   "Drug resistance patterns of human neuroblastoma cell lines derived
RT   from patients at different phases of therapy.";
RL   Cancer Res. 58:5396-5405(1998).
//
RX   PubMed=11507071;
RA   Keshelava, Nino
RA   Zuo, Juan J.
RA   Chen, Ping
RA   Waidyaratne, Sitara N.
RA   Luna, Marian C.
RA   Gomer, Charles Joseph
RA   Triche, Timothy J.
RA   Reynolds, Charles Patrick
RT   "Loss of p53 function confers high-level multidrug resistance in
RT   neuroblastoma cell lines.";
RL   Cancer Res. 61:6185-6193(2001).
//